Content uploaded by Graziella Di Grezia
Author content
All content in this area was uploaded by Graziella Di Grezia on Oct 17, 2017
Content may be subject to copyright.
VOL. 176
· No. 11
NOVEMBER 2017
!"#$%&'(%)%*"$%&&% +,--.//,%0.123,%2/,42,*,%)%,5362!27%8.5%4.%932.*-.%0.1236.% :'&
,;;"<=>?@%A"%B%<C;C?A%DCAB)B?B#EF>F%G9H%3/%
B?=%052%AC;I?>;F%;B?%JC%KC<L"<DC=%>?%AIC%=>)
agnosis without signicant differences.M
In Europe US is the rst diagnostic step in
AIC%N"<O)PK%"L% BKKC?=>;>A>FQ%3/%>F%KC<L"<DC=%
"?#E%>?%P?;C<AB>?% ;BFCF% "<% NICAIC<%>?%;BFC% "L%
AIC%BKKC?=>R%>F%>DK"FF>J#C%A"%S>FPB#>TC$
/I>F%O>?=%"L%K<"A";"#%>F%ABO>?@%I"#=%>?%F"DC%
G9,%I"FK>AB#FH%>?%#>?C%N>AI%=>LLC<C?A%#>AC<BAP<C%
<CFP#AFU
%—VBJ="D>?B#% 3/% ="CF% ?"A% >DK<"SC% "PA)
;"DC%L"<%;I>#=<C?%N>AI%FPFKC;AC=%B;PAC%BKKC?)
=>;>A>FWQ:
%—VK<CLC<C?A>B#%PFC%"L%BJ="D>?B#%3/%A"%=>)
B@?"FC%BKKC?=>;>A>F%="CF%?"A%<C=P;C%AIC%?C@B)
A>SC%BKKC?=C;A"DE%<BACW$(
0"<C"SC<%FCSC<B#%<CK"<A%K<"SC=%AIBA%G9H%>L%
,;PAC%BJ="D>?B#%KB>?%B?=%A<BPDB%<CK<CFC?A%
AIC%DB>?%;BPFC%"L%B;;CFF%A"%B?%CDC<@C?;E%
P?>A%>?%KC=>BA<>;%KBA>C?AF$&
X<CYPC?A#E%AIC%=>B@?"F>F%>F%;#>?>;B#$%/IC%D"FA%
;"DD"?%;#>?>;B#%FEDKA"DF%B<CU%?BPFCBH%S"D)
>A>?@H% B?"<CR>BH% LCSC<H% =>B<<ICBH% 5>@IA% 4"NC<%
ZPB=<B?A%BJ="D>?B#%AC?=C<?CFF$%4BJ"<BA"<>CFU%
[\3]&^^^^_D;4H% ?CPA<"KI>#>B]':`% N>AI% B%
#CLA%FI>LAH%835]a^%D@_=4$aH%b%0B?E%F;"<C%NBF%
K<CFC?AC=%A"% CR;#P=C% AIC% <>FO%"L%B;PAC% BKKC?)
=>;>A>F% ce.g.% ,SB<B="H% ,#SB<B="_0B?A<C#FH% 8C)
=>BA<>;% ,KKC?=>;>A>F% 9;"<Cd$% 6"NCSC<% &_b% "L%
;I>#=%IBSC%B?%BAEK>;B#%;#>?>;B#%K<CFC?ABA>"?%ebfH%
AIC<CL"<C%B%<B=>"#"@>;B#%BKK<"B;I%>F%DB?=BA"<E%
A"%<C=P;C%?C@BA>SC%#BKB<"A"DE% "<% =C#BEC=%BK)
KC?=>;C;A"DE%AIBA%;"P#=% JC% ;"DK#>;BAC=%N>AI%
KC<L"<BA>"?$
G#A<BF"P?=%F;"<>?@%FEFACD%L"<%B;PAC%BKKC?=>;>A>F%
>?%KC=>BA<>;%KBA>C?AFU%B%PFCLP#%A""#%L"<%AIC%FP<@C"?
+<BT>C##B%12%+5.-2,%&H%9BSC<>"%82+*,/,%aH%+>B?S>A"%8, 3 . %&H%%
1>B?B%17*,/2.447%&H%*>;"#B%9.55,%&H%+>B?#P;B%+,/ /,%&%g
&1CKB<ADC?A%"L% 5B=>"#"@EH%G?>SC<F>AE% "L%3BDKB?>B%V4P>@>%!B?S>AC##>WH%*BK#CFH% 2AB#EQ%a/<>;B<>;"%8<>SBAC%6"FK>AB#H%
\C#SC=C<C%0B<>AA>D"H%3"FC?TBH%2AB#E
g3"<<CFK"?=>?@%BPAI"<U%+>B?#P;B%+BAABH%8>BTTB%0><B@#>B%a%h^&bh%*BK#CFH%2AB#E$%.)DB>#U%@>B?#P;B$@BAABiP?>;BDKB?>B$>A
,??"U%a^&'
0CFCU%*"SCDJC<
!"#PDCU%&'(
*"U%&&
5>S>FABU%+BTTCAAB%0C=>;B%2AB#>B?B%)%,<;I>S>"%KC<%#C%9;>C?TC%0C=>;IC
3"=%5>S>FABU%+BTT%0C=%2AB#%)%,<;I%9;>%0C=
4BS"<"U%b:::)+02
A>A"#"%J<CSCU%G4/5,97G*1%93752*+%9j9/.0%X75%,3G/.%,88.*1232/29%2*%
8.12,/523%8,/2.*/9
K<>D"%BPA"<CU%12%+5.-2,
KB@>?CU%:'&)(
;>ABT>"?CU%+BTT%0C=%2AB#%)%,<;I%9;>%0C=%a^&'Q&'(U:'&)(
,\9/5,3/
\,3k+57G*1U%/IC% B>D%>F%CSB#PBAC% ?CN%G9% F>@?FH%"AIC<%AIB?% AIC%B#<CB=E%O?"N?% cK<>DB<E%B?=%FC;"?=B<EdH% AIBA%B<C%
K"F>A>SC%;"<<C#BAC=%N>AI%I>FA"KIBA"#"@>;B#%<CFP#AF%>?%KC=>BA<>;%BKKC?=>;>A>F$
0./6719U%X"<AE%KC=>BA<>;%KBA>C?AF%cM)&h%ECB<F%"#=d%N>AI%;#>?>;B#%FPFK>;>"PF%"L%BKKC?=>;>A>FH%CRBD>?BAC=%N>AI%;"?SCRH%
D>;<";"?SCR%B?=%#>?CB<%K<"JC$
5.9G4/9U%[C%"JFC<SC=%B%?C@BA>SC%#>?CB<%;"<<C#BA>"?%J"AI%P?>SB<>BAC%B?=%DP#A>SB<>BAC%B?B#EF>F%JCANCC?%?PDJC<F%"L%#BE)
C<F%B?=%DBR>DB#%"PAC<%=>BDCAC<$
37*34G927*9U%2F% K"FF>J#C% A"%;"?F>=C<%AIC% ?PDJC<%"L%#BEC<F% B?=%AIC%C;I"@C?>;>AE% KBAAC<?%"L%CB;I% #BEC<% BF%B%LP<AIC<%
P#A<BF"?"@<BKIE%=>B@?"FA>;%F>@?%>?%;BFC%"L%B;PAC%BKKC?=>;>A>F$
cCite this article as:%1>%+<CT>B%+H%8>@?BAB%9H%8B;C%+H%1"?BA>C##"%1H%9C<<B%*H%+BAAB%+$%G#A<BF"P?=%F;"<>?@%FEFACD%L"<%B;PAC%BK)
KC?=>;>A>F%>?%KC=>BA<>;%KBA>C?AFU%B%PFCLP#%A""#%L"<%AIC%FP<@C"?$%+BTT%0C=%2AB#%)%,<;I%9;>%0C=%a^&'Q&'(U:'&)($%172U%&^$ab'b(_
9^blb)b((^$&'$^b:::)^d
Key words:%,KKC?=>;>A>F%)%3I>#=%)%G#A<BF"?"@<BKIE%)%,KKC?=C;A"DE$
+BTTCAAB%0C=>;B%2AB#>B?B%)%,<;I>S>"%KC<%#C%9;>C?TC%0C=>;IC%a^&'%*"SCDJC<Q&'(c&&dU:'&)(
172U%&^$ab'b(_9^blb)b((^$&'$^b:::)^
m%a^&'%.12-27*2%02*.5!,%0.123,
7?#>?C%SC<F>"?%BA%IAAKU__NNN$D>?C<SBDC=>;B$>A
ORIGINAL ARTICLE
ORAL AND GASTROINTESTINAL DISEASES: IMAGING STATE OF THE ART
AND PSYCHOPATHOLOGICAL FEATURES
12%+5.-2,% G4/5,97G*1%93752*+%9j9/.0%X75%,3G/.%,88.*1232/29%2*%8.12,/523%8,/2.*/9
:'a% +,--.//,%0.123,%2/,42,*,%)%,5362!27%8.5%4.%932.*-.%0.1236.% *"SCDJC<%a^&'
>#C"KF"BF%BJF;CFFH%"DC?AB#%>?LB<;A>"?H%"SB<>B?%
;EFAH%?CKI<"#>AI>BF>FH%@BFA<"C?AC<>A>FH%=>SC<A>;P)
#>A>FH%;I"#C;EFA>A>FH%3<"I?d
,%;"?SCR% K<"JC% NBF%PFC=%>?% &b% KBA>C?AFH% B%
D>;<"?SCR% K<"JC% >?% h% KBA>C?AF% NI>#C% AIC% <C)
DB>?>?@% ;BFCF% NBF% BFFCFFC=% =><C;A#E% N>AI% B%
#>?CB<%K<"JC$
In some cases leg ection was required to
avoid abdominal defense reex in not compli)
B?A%KBA>C?AQ%B?ENBE%>?%B##%M^%KBA>C?A%NC%S>FPB#)
>TC=%AIC%BKKC?=>R$
/IC%G9%CRBD%NBF%KC<L"<DC=%"?#E%"?;C%B?=%
L"##"NC=%JE%FP<@>;B#%;"?FP#ABA>"?%>?%FP<C%K"F>)
A>SC%;BFCFH%NI>#C%>?%AIC%"AIC<F%>A%NBF%<CKCBAC=%BA%
B%=>FAB?;C%"L%(H%&aH%b(H%Mh%I"P<F$&M%,%NB>A%B?=%
FCC%K<";CFFH%N>AI% B% ;#>?>;B#% B?=%FP<@>;B#%A>@IA%
;"?A<"#% NBF% BKK#>C=% A"% B##% KBA>C?AF% L"<% NI"D%
NC%KC<L"<DC=%G9%D"<C%AIB?%"?;C$
[C%DB=C%B%;#"FC<%L"##"N)PK%;"?A<"#%"?#E%>?%
a%KBA>C?A%N>AI%B@CF%JCANCC?%M%B?=%:%JC;BPFC%"L%
the higher risk of perforation during the rst 36
I"P<F%>?%AI>F%B@C%@<"PK$&:)a^
[C% IBSC% ?"A% B==C=% AIC% #BJ"<BA"<>CF%<CFP#AF%
>?%AIC%FABA>FA>;B#%B?B#EF>F%nPFA%A"%P?=C<#>?C%AIC%
US ndings.
Statistical analysis
/IC% FABA>FA>;B#% B?B#EF>F% NBF% KC<L"<DC=% JE%
0BA#BJ%FABA>FA>;B#%A""#J"R%SC<F>"?%a^^h%c0BAI)
["<OFH%*BA>;OH%0,H%G9,d%L"<%[>?="NF%BA%ba%
J>AH% "?% FBDK#C% "L% M^% E"P?@% KBA>C?AFH% (^$^^`%
DB#CF% B?=% M^$^^`% LCDB#CF% N>AI% B@CF% >?A"%
<B?@C%M)&hH%N>AI%DCB?%BJ"PA%&a%E"%B?=%FAB?)
=B<=%=CS>BA>"?%csdd%BJ"PA%M%ECB<F%"#=$
1BAB%B<C%K<CFC?AC=%BF%?PDJC<%B?=%KC<;C?A)
B@CF%L"<% ;BAC@"<>;B#% SB<>BJ#CF%B?=% ;"?A>?P"PF%
=BAB%NC<C%CRK<CFFC=%BF%DCB?%o%FAB?=B<=%=CS>B)
tion (SD), unless otherwise specied. Finally
P?>SB<>BAC% B?=% DP#A>SB<>BAC% #>?CB<% ;"<<C#BA>"?%
B?B#EF>F% NC<C% KC<L"<DC=$% 2?% B==>A>"?% AIC% ACFA%
on Pearson’s linear correlation coefcient R
NBF%KC<L"<DC=%N>AI% t)9AP=C?A%ACFAH%P?=C<%?P##%
IEK"AICF>F%"L%8CB<F"?pF%#>?CB<%;"<<C#BA>"?%;")
efcient R=0. We considered signicant, all
FABA>FA>;B#%ACFAF%N>AI%8%SB#PC%q^$^:$
To dene a statistical analysis on correla)
A>"?%BD"?@%#BEC<FH%NC%;IB?;C=%AIC%YPB#>ABA>SC%
SB<>BJ#C%#BEC<%>?%YPB?A>ABA>SC%SB<>BJ#CH%BFF>@?)
KC<L"<DC=% JE% CRKC<>C?;C=% B?=% =C=>;BAC=% <B)
=>"#"@>FAFH%DBE%B;I>CSC%B%=>B@?"FA>;%B;;P<B;E%
AIBA%>A%>F%BF%@""=%BF%3/$'
9<>?>SBFB?% et al.% FP@@CFA% AIBA% 3/% IBF% #>D)
>AC=%E>C#=%NIC?%G9%B?=%,KKC?=>;>A>F%9;"<C%B<C%
;"?;"<=B?A$h
1P<>?@%AIC%#BFA% =C;B=C% AIC% G9% IBF%JC;"DC%
the rst diagnostic method vs.%3/%>?%AIC%G9,%
BF%NC##H%J"AI%L"<%<C=P;C%AIC%<>FO%"L%<B=>BA>"?)
>?=P;C=% ;B?;C<% J"AI% L"<% ;"FAF% CLLC;A>SC?CFF%
c/BJ#C%2d$l)&&
US has high specicity to rule in the diag)
?"F>F%"L%BKKC?=>;>A>FH%N>AI%SB<>BJ#C%FC?F>A>S>AE%
A"%<P#C%>A%"PA$&a
5"PA>?C% G9% >?% B##% ;I>#=<C?% N>AI% FPFKC;AC=%
BKKC?=>;>A>F%IC#KF%>?%<C=P;>?@%?C@BA>SC%BKKC?)
=>;C;A"DE%B?=%KC<L"<BA>"?%<BAC$%,%?C@BA>SC%G9%
="CF% ?"A% nPFA>LE% B% FPJFCYPC?A% B?=% >DDC=>BAC%
3/%JC;BPFC%;#>?>;B#%<C)CSB#PBA>"?%B?=%FC;"?=%
G9%;B?%;#B<>LE%AIC%=>B@?"F>F$&b
7P<%FAP=E% >F% JBFC=% "?%AIC%=>B@?"F>F% "L% BK)
KC?=>;>A>F%"?#E%N>AI%AIC%PFC%"L%G9%AC;I?>;$
/IC%B>D%NBF%A"%CSB#PBAC%?CN%G9%F>@?FH%"AIC<%
AIB?%AIC%B#<CB=E%O?"N?%cK<>DB<E%B?=%FC;"?=)
B<EdH%AIBA%B<C%K"F>A>SC%;"<<C#BAC=%N>AI%I>FA"KIB)
A"#"@>;B#%<CFP#AF$
Materials and methods
[C%<CA<"FKC;A>SC#E%<CS>CNC=%M^AI%G9%DC=>)
;B#% <C;"<=% L<"D% KC=>BA<>;% KBA>C?AF% N>AI% B@C%
>?A"%<B?@C%M%)&h%ECB<F%;"DC%A"%"P<%"JFC<SBA>"?%
L<"D%ECB<%a^&b%A"%a^&(%N>AI%B%G9%<CYPCFA%L"<%
FPFKC;AC=% BKKC?=>;>A>F% N>AI% B% K"FA)"KC<BA>SC%
IEFA";>A"KBAI"#"@>;B#%CS>=C?;C$
[C%CR;#P=C=% "AIC<F% KC=>BA<>;% FP<@>;B#% ;"?)
=>A>"?F% c>?APFFPF;CKA>"?H% 0C;OC#% =>SC<A>;P)
#PDH%IC<?>BH%ACFA>;P#B<%A"<F>"?H%,DEB?=%IC<?>BH%
Table I.—First-line standard US with CT imaging
reserved for subsequent inconclusive results.
9C?F>A>S>AE
c`d
Specicity
c`d
88!
c`d
*8!
c`d
1>B@?"FA>;
B;;P<B;E
c`d
8""<ADB? &^^ h( la &^^ l:
kB>FC< ll hl h' ll lb
3P?=Eg lh$h lh$b l:$:
\B#=>FFC<"AA"g lh$: lh$a lh lh$'
88!U% 8"F>A>SC% 8<C=>;A>SC%!B#PCQ% *8!U% *C@BA>SC% 8<C=>;A>SC% !B#PC$%
gG9%"?#E$
G4/5,97G*1%93752*+%9j9/.0%X75%,3G/.%,88.*1232/29%2*%8.12,/523%8,/2.*/9% 12%+5.-2,
!"#$%&'(%)%*"$%&&% +,--.//,%0.123,%2/,42,*,%)%,5362!27%8.5%4.%932.*-.%0.1236.% :'b
ned. Instead there was a signicant negative
;"<<C#BA>"?% >?% DP#A>SB<>BAC% B?B#EF>F% JCANCC?%
22?=%B?=%222<=%#BEC<%cX>@P<C%&d$
9PJFCYPC?A#E%NC%;"?F>=C<C=%B%DP#A>K#C%#>?)
CB<% ;"<<C#BA>"?% BD"?@% DP#A>K#C% #BEC<F% N>AI%
B@CH% FCRH% B?=% DBR% =>BDCAC<% cl$bho:$bMd$% X"<%
AI>F% F;"KC% AIC% SB<>BJ#CF% FCR% NBF% <CK<CFC?AC=%
N>AI% CRKC<>DC?AB#% K<"JBJ>#>AE% =>FA<>JPA>"?Hab%
such a that: male = 1 (success) and female = 0
cLB>#P<Cd$%X>?B##E%L"<%1"KK#C<% SB<>BJ#CH% NC%BF)
signed a value into range [0-4], where 0 = no
SBF;P#B<>TBA>"?% B?=% M% CYPB#% A"% DBR% SBF;P#B<)
>TBA>"?%cX>@P<C%ad$
>?@%BA%=>LLC<C?A%#BEC<% B% F;"<C% B;;"<=>?@% A"%AIC%
thickening degree: absence of thickening = 0,
(HYPO) = 1, iper-thickening (HYPER) = 2,
(DIS) = 3.
2?%/BJ#C%22H%NC%IB=%CSB#PBAC=%K"FF>J#C%;"<<C)
#BA>"?F%BD"?@%#BEC<F%N>AI%J"AI%P?>SB<>BAC%B?=%
DP#A>SB<>BAC%#>?CB<%;"<<C#BA>"?%B?B#EF>F$
\E%/BJ#C%22H%NC%"?#E%"JFC<SC=%>?%E"P?@%KB)
tients a good signicant negative linear corre)
#BA>"?%JCANCC?%2FA% B?=% 22?=%#BEC<H%J"AI% P?>SB<>)
BAC% B?=% DP#A>SB<>BAC% B?B#EF>F$% 2?% "AIC<% AC<DF%
JCANCC?%2FA%B?=%22?=%AIC<C%NBF%B?%>?SC<FC% ;"<)
<C#BA>"?%B;;"<=>?@%A"%AIC%AI>;OC?>?@%=C@<CC%=C)
Table II.—Univariate and multivariate linear correlation analysis among layers.
G?>SB<>BAC%B?B#EF>F 0P#A>SB<>BAC%B?B#EF>F
8B<BDCAC<F 5%c8%SB#PCd
Multiple linear correlation coefcient = 0.789
4BEC<%2%_%4BEC<%22 )^$'('%cq^$^^^&dg 5KB<A>B# = -0.788; P value< 0.0001*
4BEC<%2%_%4BEC<%222 ^$^bM%c^$hb'd 5KB<A>B# = -0.278; P value= 0.092
4BEC<%2%_%4BEC<%2! )^$^(&%c^$'&&d 5KB<A>B# = -0.111; P value= 0.509
Multiple linear correlation coefcient = 0.805
4BEC<%22%_%4BEC<%2 )^$'('%cq^$^^^&dg 5KB<A>B# = -0.788; P value< 0.0001*
4BEC<%22%_%4BEC<%222 )^$a(M%c^$&^^d 5KB<A>B# = -0.375; P value= 0.0205*
4BEC<%22%_%4BEC<%2! ^$^^%c&$^^d 5KB<A>B# = -0.094; P value= 0.573
Multiple linear correlation coefcient = 0.380
4BEC<%222%_%4BEC<%2 ^$^bM%c^$hb'd 5KB<A>B# = -0.278; P value= 0.092
4BEC<%222%_%4BEC<%22 )^$a(M%c^$&^^d 5KB<A>B# = -0.375; P value= 0.0205*
4BEC<%222%_%4BEC<%2! )^$^Mb%c^$'lbd 5KB<A>B# = -0.073; P value= 0.663
Multiple linear correlation coefcient = 0.119
4BEC<%2!%_%4BEC<%2 )^$^(&%c^$'&&d 5KB<A>B# = -0.111; P value= 0.509
4BEC<%2!%_%4BEC<%22 ^$^^%c&$^^d 5KB<A>B# = -0.094; P value= 0.573
4BEC<%2!%_%4BEC<%222 )^$^Mb%c^$'lbd 5KB<A>B# = -0.073; P value= 0.663
*Signcant tests.
X>@P<C%a$r3#PFAC<C=%DP#A>K#C%SB<>BJ#CF%@<BKIU%B@CH%DBR%=>)
BDCAC<H%SBF;P#B<>TBA>"?%B?=%*$%#BEC<F%JE%9CR$
X>@P<C%&$r3#PFAC<C=%DP#A>K#C%SB<>BJ#CF%@<BKIU%B@CH%DBR%=>)
BDCAC<F%B?=%SBF;P#B<>TBA>"?H%JE%*$%#BEC<F$
12%+5.-2,% G4/5,97G*1%93752*+%9j9/.0%X75%,3G/.%,88.*1232/29%2*%8.12,/523%8,/2.*/9
:'M% +,--.//,%0.123,%2/,42,*,%)%,5362!27%8.5%4.%932.*-.%0.1236.% *"SCDJC<%a^&'
9>?;C%AIC%l^F%NBF%K<"SC=%AIC%;"<<C#BA>"?%JC)
ANCC?%BKKC?=>;>A>F%B?=%B%<>F>?@%>?%AIC%1"KK#C<%
SBF;P#B<>TBA>"?Qa&% I"NCSC<% B#AI"P@I% AIC% SBF)
\E%/BJ#C%222%NC%"JFC<SC=%B%?C@BA>SC%#>?CB<%
;"<<C#BA>"?% J"AI% P?>SB<>BAC% B?=% DP#A>SB<>BAC%
B?B#EF>F%JCANCC?%*<$%#BEC<F%B?=%DBR%=>BDCAC<$%
2?%"AIC<%AC<DF%DBR%=>BDCAC< NBF%?C@BA>SC%F>@)
nicant predictor of Nr. layers, i.e.%B?%>?;<CBF)
>?@% "L% =>BDCAC<% NBF% ;"<<C#BAC=% B% =C;<CBF>?@%
"L%AIC%?PDJC<%"L% #BEC<F$% X>?B##E%AIC%B@C%NC<C%
?C@BA>SC#E%;"<<C#BAC=%N>AI%Sex "?#E%>?%P?>SB<>)
BAC%B?B#EF>F%cX>@P<C%bd$
Results
/I><AE)F>R% "PA% "L% M^% KBA>C?AF% IB=% B% 071%
](DDQ%b^%"L%AICD%IB=%B%071%]'DD$
/IC% DBR>DPD% 071% SB#PC% <C@>FAC<C=% NBF%
bh$:DD%>?%B%&h%ECB<F%"#=%DB#C%N>AI%nPFA%"?C%
IEKC<%#BEC<%cDBR%=>BDCAC<%NBF%?C@BA>SC%F>@?>L)
>;B?A% K<C=>;A"<% "L% *$"L% #BEC<FdQ% AIC% D>?>DPD%
071%SB#PC%NBF%bDD%>?%B%&:%ECB<F%"#=%LCDB#CH%
with a hypo-hyper-hypo wall stratication and
N>AI%B% ;"#"<)1"KK#C<%F>@?B#%"L%gg$%.#CSC?%"PA%
"L%M^%IB=%B%K"F>A>SC%3"#"<1"KK#C<%F>@?B#%cD>?)
>DPD%^)%DBR>DPDd$
Figure 3.—Signicant linear correlation graph between max
=>BDCAC<%B?=%*$%#BEC<F%N>AI%K<C=>;A%>?AC<SB#%BA%l:`$%/IC%K<C)
=>;A%>?AC<SB#%BA% l:`% NBF%<CK<CFC?AC=%JE% AN"% ;P<SCF$%/ICFC%
;P<SCF%<CK<CFC?A%AIC%l:`%K<C=>;A>"?%>?AC<SB#%L"<%AIC%<C@<CF)
F>"?%;P<SC$
Table III.—Univariate and multivariate linear correlation analysis among age, sex, max diameter, vascularization
and N. layers.
G?>SB<>BAC%B?B#EF>F 0P#A>SB<>BAC%B?B#EF>F
8B<BDCAC<F 5%c8%SB#PCd
Multiple linear correlation coefcient = 0.483
,@C%_%9CR )^$bh:%c^$^&Madg 5KB<A>B# = -0.268; P value= 0.108
,@C%_%DBR%=>BDCAC< ^$&lb%c^$a&^d 5KB<A>B# = 0.301; P value= 0.070
,@C%_%!BF;P#B<>TBA>"? ^$&'&%c^$&l&d 5KB<A>B# = 0.113; P value= 0.506
,@C%_%*<$%4BEC<F ^$MM&%c^$&&bd 5KB<A>B# = 0.172; P value= 0.310
Multiple linear correlation coefcient = 0.495
9CR%_%,@C )^$bh:%c^$^&Madg 5KB<A>B# = -0.268; P value= 0.108
9CR%_%DBR%=>BDCAC< )^$&&h%c^$M(ld 5KB<A>B# = -0.198; P value= 0.241
9CR%_%!BF;P#B<>TBA>"? )^$a&(%c^$&h&d 5KB<A>B# = -0.136; P value= 0.421
9CR%_%*<$%4BEC<F )^$a'l%c^$^had 5KB<A>B# = -0.296; P value= 0.075
Multiple linear correlation coefcient = 0.606
DBR%=>BDCAC<%_%,@C ^$&lb%c^$a&^d 5KB<A>B# = 0.301; P value= 0.070
DBR%=>BDCAC<%_%9CR )^$&&h%c^$M(ld 5KB<A>B# = -0.198; P value= 0.241
DBR%=>BDCAC<%_%!BF;P#B<>TBA>"? )^$^h(%c^$:lld 5KB<A>B# = -0.072; P value= 0.672
DBR%=>BDCAC<%_%*<$%4BEC<F )^$MhM%c^$^^&(dg 5KB<A>B# = -0.554; P value= 0.0004*
Multiple linear correlation coefcient = 0.285
!BF;P#B<>TBA>"?%_%,@C ^$&'&%c^$&l&d 5KB<A>B# = 0.113; P value= 0.506
!BF;P#B<>TBA>"?%_%9CR )^$a&(%c^$&h&d 5KB<A>B# = -0.136; P value= 0.421
!BF;P#B<>TBA>"?%_%DBR%=>BDCAC< )^$^h(%c^$:lld 5KB<A>B# = -0.072; P value= 0.672
!BF;P#B<>TBA>"?%_%*<$%4BEC<F ^$a^&%c^$a&:d 5KB<A>B# = 0.083; P value= 0.624
Multiple linear correlation coefcient = 0.612
*<$#BEC<F%_%,@C ^$MM&%c^$&&bd 5KB<A>B# = 0.172; P value= 0.310
*<$#BEC<F%_%9CR )^$a'l%c^$^had 5KB<A>B# = -0.296; P value= 0.075
*<$#BEC<F%_%DBR%=>BDCAC< )^$MhM%c^$^^&(dg 5KB<A>B# = -0.554; P value= 0.0004
*<$#BEC<F%_%!BF;P#B<>TBA>"? ^$a^&%c^$a&:d 5KB<A>B# = 0.083; P value= 0.624
*Signicant tests.
G4/5,97G*1%93752*+%9j9/.0%X75%,3G/.%,88.*1232/29%2*%8.12,/523%8,/2.*/9% 12%+5.-2,
!"#$%&'(%)%*"$%&&% +,--.//,%0.123,%2/,42,*,%)%,5362!27%8.5%4.%932.*-.%0.1236.% :':
K<C=>;AF%B;PAC%BKKC?=>;>A>F$%7AIC<%;<>AC<>B%FP;I%
BF% =>BDCAC<% FI"P#=% JC% BS">=C=Q% =>BDCAC<H%
?"?);"DK<CFF>J>#>AEH% IEKC<CD>BH% K<CFC?;C% "L%
appendicolith, loss of stratication of the ap)
KC?=>;CB#% NB##% ="% ?"A% >?=CKC?=C?A#E% K<C=>;AF%
BKKC?=>;>A>F$a^
[C%L"P?=C=%"AIC<%BFKC;AF%A"%;"?F>=C<%=P<>?@%
AIC%P#A<BF"P?=%CRBD>?BA>"?H%>C%AIC%C;I"@C?>;>)
AE%_%AI>;OC?>?@%"L%AIC%BKKC?=>;CB#%NB##$
8B<A>;P#B<#EU
%—BA%AIC%>?;<CBFC%"L%DBR>DPD%BKKC?=>;P)
#B<%=>BDCAC<%AIC<C% >F% B?% >?;<CBFC%>?%AIC% AI>;O)
?CFF_C;I"@C?>;>AE%"L%AIC%CRAC<?B#% #BEC<% N>AI%B%
=C;<CBFC%"L%AI>;OC?CFF%"L%AIC%FC;"?=%#BEC<Q
%—AIC% DBR>DPD% =>BDCAC<% >F% D"<C% K<CSB)
#C?A% >?% DB#C% K"KP#BA>"?% ;"DKB<C=% A"% LCDB#C%
@<"PK%B?=%AI>F%=BAC%>F%;"?F>FAC?A%N>AI%#>AC<BAP<C%
CRKC<>C?;CQ
%—@C?=C<% ="CF% ?"A% BLLC;A% AIC% ?PDJC<% "L%
#BEC<F%JPA%"?#E%AIC%SBF;P#B<>TBA>"?%cX]0dQ
%—the most representative stratication
KBAAC<?%JBFC=%"?%#BEC<%C;I"@C?>;>AE%B<CU
&d%&'%IEK")IEKC<)IEK"Q
ad% l% IEK")IEKC<)=>F"D"@C?CPFH% ;"?)
sistent with “target sign” (3 layers= hypo:
DPF;"#B<>F%DP;"FBC%)%IEKC<U% DP;"FBC_FPJ)
DP;"FBC% s% IEK"_B?C;"@U% >?A<BKKC?=>;P#B<%
uid);
%—max diameter was negative signicant
K<C=>;A"<%"L%*<$%#BEC<F%>$C$%B?%>?;<CBF>?@%"L%=>)
BDCAC<% NBF% ;"<<C#BAC=% N>AI% B% =C;<CBFC% >?% AIC%
?PDJC<%"L%#BEC<F$a&)ab
/IC<C%>F%B%SB#>=%FABA>FA>;%;"<<C#BA>"?%JCANCC?%
AIC%K<CFC?;C%"L%B;PAC%BKKC?=>;>A>F%B?=%"?C%"L%
the stratication pattern, independently from
AIC%DBR>DPD%BKKC?=>;P#B<%=>BDCAC<%B?=%3"#)
"<1"KK#C<%F>@?B#%F;"<C$
/I>F%;"P#=%JC%<C#BAC=%N>AI%AIC%KIEF>"KBAI")
logic mechanism of inammation (vasocon)
FA<>;A>"?H% SBF"=>#BABA>"?H% C=CDBH% ;ICD"ABR>FH%
CRP=BACd%B?=%N>AI%AIC%A>DC%"L%G9%CRC;PA>"?$aa
/IC%=>B@?"F>F%"L%B;PAC%BKKC?=>;>A>F%>?%KC=>)
BA<>;%K"KP#BA>"?% >F% "LAC?% IB<=% B?=%B% D"FA% G9%
specic sign does not exist, but one or more
US ndings can orient the diagnosis.
It is not always possible to conrm the clini)
;B#%FPFK>;>"?%"L%B;PAC%BKKC?=>;>A>F%N>AI%<B=>")
#"@>;B#%G9%>DB@>?@%AC;I?>YPCH%JBFC=%"?%<CB=)
>?@%AIC% 071% B#"?C% "<% BFF";>BA>?@%N>AI% "AIC<%
cularity of normal and inamed appendix may
JC%=>LLC<C?AH%AI>F%=>LLC<C?;C%NBF%?"A%B%@""=%=>)
B@?"FA>;%>?=>;BA"<%"L%BKKC?=>;>A>F$a&H%aa
[C% L"P?=% AIC% K<CFC?;C% "L% >?A<BKC<>A"?CB#%
uid just in 4 patient and so neither the quan)
A>AE%?"<%AIC%AEK"#"@E%NBF%<CK"<AC=Q%>?%"?#E%"?C%
;BFC%NC%L"P?=%B?%BKKC?=>;"#>AI$
Discussion
8PE#BC<A%K<"SC=H%>?%AIC%&lh(H%AIBA%AIC%V>=C?)
tication in RLQ of a non-compressible blind)
C?=>?@%FA<P;AP<C%N>AI%B?%"PAC<%=>BDCAC<%@<CBAC<%
AIB?%(%DDW%c@<B=C=%;"DK<CFF>"?d%>F%=>B@?"F)
A>;%L"<%BKKC?=>;>A>F$&(
This diagnostic approach was conrmed in
AIC%a^^MU%V,%AI<CFI"#=%(%DD%=>BDCAC<%"L%AIC%
BKKC?=>R%P?=C<%;"DK<CFF>"?%>F%AIC%D"FA%B;;P)
rate US nding for appendicitis and has high
*8!%B?=%88!W$&'
8<>DB<E% ;<>AC<>"?% L"<% AIC% G9% =>B@?"F>F% "L%
BKKC?=>;>A>F%>F% B?% BKKC?=>;CB#%DBR>DB#% "PAC<%
=>BDCAC<% c071d% C?#B<@CDC?A% JCE"?=% (% DD%
(most specic sign). Secondary criteria in)
;#P=C% KC<>)BKKC?=>;CB#% IEK"C;I">;% IB#"% BF)
F";>BAC=% N>AI% NB##% C=CDBH% BKKC?=>;CB#% NB##%
thickness ≥3 mm, wall hyperemia on color
1"KK#C<% CRBDH% C;I"@C?>;% C=CDBA"PF% DCFC?)
AC<>;%LBA%FA<B?=>?@H% B?=%AIC%K<CFC?;C%"L% B?%BK)
KC?=>;"#>AI$
6"NCSC<% >?% AIC% L"##"N>?@% ECB<F% "AIC<% BP)
AI"<F%PA>#>TC=% B% ;PA)"LL%071%"L% '% DD%&h%B?=%
also added other US ndings, for instance
+"#=>?%et al.%<CK"<AC=%AIBAHW%>?;<CBFC=%G9%FC?)
sitivity and specicity for the diagnosis of ap)
KC?=>;>A>F%N"P#=%JC%B;I>CSC=%>L%AIC%=>B@?"FA>;%
criteria were dened as a MOD of ≥7.5 mm
B#"?CH%"<%B%071%<B?@>?@%JCANCC?%($^%B?=%'$M%
DD%N>AI%BA%#CBFA%"?C%FC;"?=B<E%G9%F>@?H%FP;I%
as appendiceal hyperemia, focal uid collec)
A>"?H%K<CFC?;C%"L%B%LC;B#>AIH%B?=_"<%IEKC<C;I">;%
or inamed mesenteric fat. In addition, wall
AI>;O?CFF%B#"?C%D>@IA%JC%B?%>DK"<AB?A%SB<>BJ#C%
BLLC;A>?@%"PA;"DCF$W&l
0"<C"SC<% "AIC<% BPAI"<F% K<"SC=% AIBA% AIC%
MOD specicity was not signicant and ap)
K#>C=%"?#E%AIC%FC;"?=B<E% ;<>AC<>BU% t>?% B% DP#A>)
variate analysis, inammation of periappen)
diceal fat is the only nding that statistically
12%+5.-2,% G4/5,97G*1%93752*+%9j9/.0%X75%,3G/.%,88.*1232/29%2*%8.12,/523%8,/2.*/9
:'(% +,--.//,%0.123,%2/,42,*,%)%,5362!27%8.5%4.%932.*-.%0.1236.% *"SCDJC<%a^&'
A>B@"% 0C=>?B% 4H% 1"<>B%,9% ,;PAC% BKKC?=>;>A>F% >?% E"P?@%
;I>#=<C?U% ;"FA)CLLC;A>SC?CFF% "L% G9% SC<FPF% 3/% >?% =>B@)
?"F>F)% B% 0B<O"S% =C;>F>"?% B?B#EA>;% D"=C#% 5B=>"#"@E%
a^^lXCJQa:^Ub'h)bh(
&a$%.#>OBFIS>#>% 2H%/BE%./H%/FP?@%u[H%/IC% CLLC;A%"L% K">?A)"L)
;B<C% P#A<BF"?"@<BKIE% "?% CDC<@C?;E% =CKB<ADC?A% #C?@IA%
"L%FABE%B?=%;"DKPAC=%A"D"@<BKIE%PA>#>TBA>"?%>?%;I>#=<C?%
N>AI%FPFKC;AC=%BKKC?=>;>A>F%,;B=CD>;%.DC<@C?;E%0C=>)
;>?C%a^&MQa&U&(b)&'^
&b$%8BFA"<C%!H%3";"DBTT>%5H%\BF>#C%,H%8BFA"<C%0H%\B<A"#>%XH%
4>D>AF%B?=% B=SB?AB@CF%"L%BJ="D>?B#% P#A<BF"?"@<BKIE% >?%
;I>#=<C?%N>AI%B;PAC%BKKC?=>;>A>F%FE?=<"DC%,L<>;B?%u"P<)
?B#%"L%8C=>BA<>;%9P<@C<E%a^&M
&M$% \B;IP<%5+H%1BEB?%89H%\BnBn%4H%0B;>BF%3+H%02AAB#%0kH%
9ACSC?F"?%01H%1P=#CE%*3H%9>?;#B><%kH%\C??CAA%uH%0"?P)
ACBPR%03H%kIB<JB?=B%,\H%/IC%CLLC;A%"L%BJ="D>?B#%KB>?%
=P<BA>"?%"?%AIC%B;;P<B;E%"L%=>B@?"FA>;%>DB@>?@%L"<%KC=>)
BA<>;%BKKC?=>;>A>F%,??%.DC<@%0C=%a^&aQ(^U:ha):l^
&:$% 9"DDBH%X$H%XB@@>B?H%,$H% 9C<<BH%*$H% +BAABH%+$H%2B;"JC##>FH%
X$H%\C<<>AA"H%1$H%5C@>?C##>H%,$H%1>%0>T>"H%!$H%3BKKBJ>B?;BH%
9$H% 1>% 0>T>"H% 5$H% +<BFF>H% 5$% \"NC#% >?APFFPF;CKA>"?F% >?%
B=P#AFU% AIC% <"#C% "L% >DB@>?@% ca^&Md% 5B=>"#"@>B% 0C=>;BH%
&a^HKK$%&^:)&&'$
&($%8PE#BC<A% u\H% ,;PAC% BKKC?=>;>A>FU% G9% CSB#PBA>"?% PF>?@%
@<B=C=%;"DK<CFF>"?%5B=>"#"@E%&lh(Q&:hUb::)b(^
&'$% kCFF#C<%*H%3EACSB#%3H% +B##>R%\H% 4CF?>O%,H% \#BEB;% 80H%
8Pn"#% uH% \<PC#% u0H% /B"P<C#% 8% ,KKC?=>;>A>FU% CSB#PBA>"?%
of sensitivity, specicity, and predictive values of US,
Doppler US, and laboratory ndings Radiology 2004
XCJQab^UM'a)h
&h$%8<C?=C<@BFA% 80H% ,;PAC% BKKC?=>;>A>FU% >?SCFA>@BA>?@% B?%
"KA>DB#%"PAC<%BKKC?=>;CB#%=>BDCAC<%;PA)K">?A%>?%B%KC=>)
BA<>;% K"KP#BA>"?% /IC% u"P<?B#% "L% .DC<@C?;E% 0C=>;>?C%
a^&MQ&:')&(M
&l$% +"#=>?%,\H%kIB??B%8H%/IBKB%0H%0;\<""D%u,H%+B<<>F"?%
00H%8B<>F>%0/%5CS>FC=%P#A<BF"P?=%;<>AC<>B%L"<%BKKC?=>)
;>A>F% >?% ;I>#=<C?% >DK<"SC% =>B@?"FA>;% B;;P<B;E% 8C=>BA<>;%
5B=>"#"@E%a^&&QM&Ullb)l
a^$%/<"PA% ,/H% 9B?;ICT% 5H% 4B=>?")/"<<CF% 0XH% 5CCSB#PBA>?@%
AIC% F"?"@<BKI>;% ;<>AC<>B% L"<% B;PAC% BKKC?=>;>A>F% >?% ;I>#)
=<C?U%B%<CS>CN%"L%#>AC<BAP<C%B?=%B%<CA<"FKC;A>SC%B?B#EF>F%"L%
aM(%;BFCF%,;B=%5B=>"#%a^&a%*"SQ&lc&&dU&bha)lM
a&$%8BA<>YP>?%6\H%,KKC?=>;>A>F%>?%;I>#=<C?%B?=%E"P?@%B=P#AFU%
="KK#C<% F"?"@<BKI>;)KBAI"#"@>;% ;"<<C#BA>"?% ,u5% &ll(%
0B<Q&((Q(al)bb
22. Quillin SP, Siegel MJ, Appendicitis: efcacy of color
1"KK#C<%F"?"@<BKIE%5B=>"#"@E$%&llM%0BEQ&l&U::')(^
ab$%2"SC?CH% 0$% 5$H% \"DJB;CH% X$H% 0B<CF;BH% 5$H% 9BK"?CH% ,$H%
2B<=>?"H% 8$H% 8>;B<=>H% ,$H% et al$H% 2?ACFA>?B#% 1EFJ>"F>F% B?=%
jCBFA% 2F"#BA>"?% >?% 9A""#% "L% 9PJnC;AF% N>AI% ,PA>FD% 9KC;)
A<PD%1>F"<=C<F$%0E;"KBAI"#"@>BH%&)&:$
aM$% \B#=>FFC<"AA"%0H% 8C#CAA>%,\H%2F% ;"#"P<%1"KK#C<% F"?"@<B)
KIE%B%@""=%DCAI"=%A"%=>LLC<C?A>BAC%?"<DB#%B?=%BJ?"<DB#%
BKKC?=>;CF% >?% ;I>#=<C?v% 3#>?% 5B=>"#% a^^'% ,K<Q(aUb(:)
b(l
a:$% !B#C?A>?>H%!$H%\PYP>;;I>"H%+$4$H%+B##PTT"H%0$H%2B??>C##"H%
9$H%1>%+<CT>BH%+$H%,DJ<"F>"H%5$H%/<>?;>H%0$H%0>C#CH%!$%2?)
tussusception in adults: The role of MDCT in the identi)
;BA>"?%"L%AIC%F>AC%B?=%;BPFC%"L%"JFA<P;A>"?%ca^&(d%+BFA<")
C?AC<"#"@E%5CFCB<;I%B?=%8<B;A>;CH%a^&(
a($%3BKKBJ>B?;B% 9H% +<B?BAB% !H% 1>% +<CT>B% +H% 0B?=BA"% jH%
5C@>?C##>%,H%1>%0>T>"%!H%+<BFF>%5H%5"A"?="%,%/IC%<"#C%"L%
?BF"C?AC<>;%>?APJBA>"?%>?% AIC% 05% FAP=E%"L%KBA>C?AF% N>AI%
3<"I?pF%=>FCBFCU%"P<%CRKC<>C?;C%B?=%#>AC<BAP<C%<CS>CN%5B)
=>"#"@>B%0C=>;B%ca^&&d%&&(Ubhl)M^(
ndings such as color Doppler or the presence
of intraperitoneal uid between the loops.a^)a:
X"<%AI>F%<CBF"?%>F%D"<C%BKK<"K<>BAC%A"%B?B)
#ETC%AIC%P#A<BFA<P;AP<C%"L%AIC%BKKC?=>;CB#%NB##U%
SBF;P#B<>TBA>"?%c;"#"<_8"NC<% 1"KK#C<dH% =>BD)
eter modication, wall thickening and all other
F>@?F%B#<CB=E%N>=C#E%=CF;<>JC=%>?%AIC%#>AC<BAP<C$
Conclusions
,;;"<=>?@%A"%"P<%G9%<CFP#AFH%>A%>F%?"A%;"<<C;A%
A"%FKCBO%"L% K<>DB<E% B?=% FC;"?=B<E% F>@?FH%JPA%
more properly of US ndings suggestive of ap)
KC?=>;>A>F%FP;I%PF%AIC%?PDJC<%"L%#BEC<F%B?=%AIC%
C;I"@C?>;>AE%KBAAC<?%"L%CB;I%#BEC<$
References
% &$%3B<AE%60H%8C=>BA<>;%CDC<@C?;>CFU%?"?)A<BPDBA>;%BJ="D)
>?B#%CDC<@C?;>CF%.P<%5B=>"#$%a^^a%1C;Q&ac&adUahb:)Mh
% a$%,#SB<B="%,H%,%K<B;A>;B#% F;"<C%L"<%AIC% CB<#E% =>B@?"F>F%"L%
B;PAC%BKKC?=>;>A>F%,??%.DC<@%0C=%&lh(Q&:U::')(M
% b$% 9>S>A%3XH%9>C@C#%0XH%,KK#C@BAC%k.H%*CNDB?%k1H%[IC?%
BKKC?=>;>A>F% >F% FPFKC;AC=% >?% ;I>#=<C?% 5B=>"+<BKI>;F%
a^^&Qa&UaM')a(a
% M$%-IB?@%6H%4>B"%0H%3IC?%uH%-IP%1H%\EB?nP%9H%G#A<BF"P?=H%
;"DKPAC=% A"D"@<BKIE% "<% DB@?CA>;% <CF"?B?;C% >DB@>?@)%
NI>;I%>F%K<CLC<<C=%L"<% B;PAC% BKKC?=>;>A>F% >?% ;I>#=<C?v%,%
DCAB)B?B#EF>F%8C=>BA<%5B=>"#%a^&(
% :$% 0>B?"%12H%9>#S>F%50H%8"KK%u0H%3P#JC<AF"?%03H%3BDK)
JC##%\H%9D>AI%95H%,J="D>?B#%3/%="CF%?"A%>DK<"SC%"PA)
;"DC%L"<%;I>#=<C?%N>AI%FPFKC;AC=%B;PAC%BKKC?=>;>A>F%[CFA%
u%.DC<@%0C=%a^&:%1C;%&(Ul'M)lha
% ($%3P;;P<P##"H% !$H%3>";CH% X$H%9>;BH%,$H%2BF>C##"H%X$H%3BKBFF"H%
5$H% +BAABH% +$H% 5PJ>?>H% +$% +BFA<"C?AC<>;% =>FCBFCF% >?% AIC%
AI><=%D>##C??>PDU%,%<BA>"?B#%BKK<"B;I%A"%"KA>DB#%>DB@>?@%
AC;I?>YPC%B?=%KBA>C?A% FC#C;A>"?%ca^&ad%5C;C?A>% 8<"@<CFF>%
>?%0C=>;>?BH%&^b%c&&dH%KK$%Ma()Mb^$
% '$%6"#F;IC<%63H%6C>n%6,H%2DB@>?@%"L%B;PAC%BKKC?=>;>A>F%>?%
;I>#=<C?U% .G% SC<FPF% G$9$w% "<% G9% SC<FPF% 3/v%,% .P<")
KCB?%K<"FKC;A>SC%8C=>BA<>;%5B=>"#"@E%a^^l%blUMl')Mll
% h$% 9<>?>SBFB?%,H%9C<SBCF%9H%8C?B%,H%1B<@C%kH%GA>#>AE%"L%3/%
BLAC<%F"?"@<BKIE%L"<% FPFKC;AC=% BKKC?=>;>A>F% >?% ;I>#=<C?U%
>?AC@<BA>"?%"L%B%;#>?>;B#%F;"<>?@%FEFACD%N>AI%FAB@C=%>DB@)
>?@%K<"A";"#%.DC<@%5B=>"#%a^&:QaaUb&)Ma
% l$% !B?%,AAB%,uH%\BFO>?% 6uH%0BSCF%3kH%5"##>?F%01H% \"#AC%
5+H%0P?="<LL%0\H%,?=<CNF%98H%1B?F>C%10%2DK#CDC?A)
>?@%B?%P#A<BF"P?=)JBFC=%K<"A";"#%L"<% =>B@?"F>?@% BKKC?)
=>;>A>F% NI>#C% DB>?AB>?>?@% =>B@?"FA>;% B;;P<B;E% 8C=>BA<$%
5B=>"#%a^&:QM:U('h)(h:
&^$% k"AB@B#% 0H% 5>;IB<=F% 0kH% 3IBKDB?% /H% X>?;I% 4H% 0;)
3B??%\H% 7<DBTBJB#%,H%5PFI%5uH%+"#=>?%,\H%2DK<"S>?@%
P#A<BF"P?=% YPB#>AE% A"% <C=P;C% ;"DKPAC=% A"D"@<BKIE% PFC%
>?%KC=>BA<>;%BKKC?=>;>A>FU%AIC%9BLC%B?=%9"P?=%;BDKB>@?%
,DC<>;B?%u"P<?B#%"L%9P<@C<E%a^&:Qa^lUhl()l^^
&&$% [B?%0uH% k<BI?% 0H% G?@B<% [uH% 3BOP% .H% 9P?@% 4H% 9B?)
Conicts of interest.—The authors certify that there is no conict of interest with any nancial organization regarding the material
=>F;PFFC=%>?%AIC%DB?PF;<>KA$
0B?PF;<>KA%B;;CKAC=U%0BE%a:H%a^&'$%)%0B?PF;<>KA%<C;C>SC=U%0BE%&hH%a^&'$
This document is protected by international copyright laws. No additional reproduction is authorized. It is per mitted for personal use to download and save only one file and print only one copy of this Article. It is not permitted to make additional copies
(either sporadically or systematically, either printed or electronic) of the Article for any purpose. It is not permitted to distr ibute the electronic copy of the ar ticle through online internet and/or intranet file sharing systems, electronic mailing or any other
means which may allow access to the Article. The use of all or any par t of the Article for any Commercial Use is not per mitted. The creation of derivative works from the Article is not permitted. The production of reprints for personal or commercial use is
not permitted. It is not per mitted to remove, cover, overlay, obscure, block, or change any copyright notices or terms of use which the Publisher may post on the Article. It is not permitted to frame or use framing techniques to enclose any trademark, logo,
or other proprietary information of the Publisher.